Trials / Conditions / Metastatic Malignant Neoplasm to Brain

Metastatic Malignant Neoplasm to Brain

8 registered clinical trials studyying Metastatic Malignant Neoplasm to Brain — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Neurocognitive Outcome of Bilateral or Unilateral Hippocampal Avoidance WBRT With Memantine for Brain Metastas NCT04801342	National Taiwan University Hospital	Phase 2
Recruiting	Palbociclib and Pembrolizumab In Central Nervous System Metastases NCT02896335	Massachusetts General Hospital	Phase 2
Unknown	Neurocognitive Outcome of Conformal WBRT w/wo Hippocampal Avoidance for Brain Metastases NCT02393131	National Taiwan University Hospital	N/A
Terminated	Study of the Combination of KD019 and Trastuzumab in Subjects With HER2-Positive Metastatic Breast Cancer NCT02154529	Kadmon Corporation, LLC	Phase 1 / Phase 2
Completed	Study of 4-Demethyl-4-cholesteryloxycarbonylpenclome (DM-CHOC-PEN) in Patients With Brain Tumors NCT02038218	DEKK-TEC, Inc.	Phase 2
Completed	Hypofractionated Stereotactic Radiosurgery in Treating Patients With Large Brain Metastasis NCT01705548	Emory University	N/A
Completed	Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brai NCT01332929	Centre Francois Baclesse	Phase 1
Completed	Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases NCT00928226	Stanford University	N/A